Omalizumab Home>Pharmacy>Drugs_and_Medications>O>Omalizumab     Web Pages Xolair: New Hope for Asthma and Allergy Sufferers Article about this medication under development by Genentech, from Vanderbilt University. The Johns Hopkins Gazette: May 10, 1999 Article about clinical testing of the experimental anti-allergy agent Anti-IgE, in a version called rhuMAb-E25. Xolair (Omalizumab) Manufacturer's website describes how this medication works and discusses its approval status in various countries. FDA Approves Omalizumab (Xolair), a Recombinant Anti-IgE Antibody, to Treat Allergic Rhinitis and Allergic Asthma June 2003 article on the drug's US approval. Includes information about results of clinical trials. Xolair Full prescribing information from RxList. Xolair - FamilyDoctor.org Information for patients in English or Spanish.